Esperion Therapeutics

Entity > Corporation > US > New York City New York > Esperion Therapeutics

About Esperion Therapeutics

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Esperion Therapeutics

Company Attribute Value
Name Esperion Therapeutics
Url esperion
Google google
Wikidata wikidata

Esperion Therapeutics

us

New York City, US
10 Feb 2024

New York City, US
10 Feb 2024

Esperion Therapeutics

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://en.wikipedia.org › wiki › Esperion_Therapeutics
Esperion Therapeutics
https://finance.yahoo.com › quote › ESPR
Esperion Therapeutics, Inc. (ESPR) Stock Price, News, ...
https://www.google.com › quote › ESPR:NASDAQ
Esperion Therapeutics Inc (ESPR) Stock Price & News
https://www.linkedin.com/company/esperion-therapeutics
Esperion
https://www.marketwatch.com › ... › Stocks › United States
Esperion Therapeutics Inc. Stock Quote (U.S. - ESPR
https://www.cnbc.com › quotes › ESPR
ESPR: Esperion Therapeutics Inc - Stock Price, Quote and ...
Related Searches
Related Searches
Esperion therapeutics stock
Esperion therapeutics stock price
esperion therapeutics news
Knowledge Panel
Knowledge Panel

Esperion Therapeutics (Pharmaceutical company)

esperion.com/

Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

en.wikipedia.org/wiki/Esperion_Therapeutics
  • Stock price : ESPR (NASDAQ) $2.58 0.00 (0.00%)Feb 9, 4:00 PM EST - Disclaimer
  • Headquarters : Vero Beach, FL
  • President : Sheldon Koenig
  • Founded : May 1998
  • Key people : Timothy M. Mayleben (president and CEO)

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 85108